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A report in this issue describes ‘‘chromothripsis,’’ a newmechanism for genetic instability in cancer
cells. Chromothripsis appears to be a cataclysmic event in which a single chromosome is frag-
mented and then reassembled. The phenomenon raises important questions of how chromosome
rearrangements can be confined to defined genome segments.We tend to think of tumor evolution as
the gradual acquisition of mutations that
can occur with a uniform chance across
the whole genome: a series of genetic
changes that stimulate growth, attenuate
cell death, destroy checkpoint controls,
promote further genetic instability, and
enable metastasis (Stratton et al., 2009;
Nowell, 1976). For many tumors, this
idea of gradual alteration of the genome
matches the appearance of tumors under
the microscope, where malignant lesions
can develop from benign lesions. How-
ever, this is not always the case. Cancer
genomes can also evolve by ‘‘punctuated
equilibrium’’-like mechanisms in which
one-off cataclysmic events generate the
potential for multiple concurrent muta-
tions. For example, critical shortening
of telomeres triggers breakage-fusion-
bridge cycles that result in gene amplifica-
tion and other chromosome rearrange-
ments (McClintock, 1941; Sahin and
Depinho, 2010). Developing tumor cells
can also make a single large evolutionary
step by failing cytokinesis, whereby the
doubling of the centrosome number
produces a storm of aneuploidy (Fujiwara
et al., 2005). In this issue ofCell, Stephens
et al. (2011) describe a new type of cata-
clysmic event that they call chromothrip-
sis (Greek; chromos for chromosome,
thripsis for shattered into pieces) in which
chromosomes are broken into many
pieces and then stitched back together
(Figure 1).These findings come amidst a flood of
information from the large-scale rese-
quencing of cancer genomes, which is
providing important insights into the
evolutionary paths available to developing
cancers (Stratton et al., 2009). Such
efforts help to identify changes that con-
tribute to tumorigenesis, but also may
reveal ‘‘passenger’’ alterations that create
potential burdens on tumor cells that
could be exploited for therapeutics.
Thus, understanding the ways that cancer
genomes can evolve is important; the un-
derlying evolutionary mechanisms should
constrain the composition of the chromo-
somes in the mature tumor cell.
In their current work, Stephens et al.
use paired-end next-generation se-
quencing across multiple cancer samples
to determine chromosomal structure and,
in particular, the breakpoints of copy
number alterations. With this approach,
they have identified a new type of chro-
mosomal disruption in cancer whereby
there are repeated switches in copy
number state along the length of a chro-
mosome or other genomic segment, often
with hundreds of breakpoints within a
chromosome arm. The chromosomal
segments vary in copy number primarily
by single segment changes: for example,
a region with two copies would be fol-
lowed by a single copy, followed by two,
followed by three (Figure 1). Strikingly,
these alterations are primarily limited to
a single chromosome or, in some cases,Cella few chromosomes that appear to be
co-coordinately altered. As the chromo-
somes appear to be shattered and then
stitched back together, they have coined
the term chromothripsis. A combination
of genome resequencing and analysis of
single-nucleotide polymorphism arrays
in cell lines and primary tumors suggests
that chromothripsis occurs in 2%–3% of
cancers, spanning a wide variety of tumor
types. In certain tumors, such as osteo-
sarcomas and chordomas, chromothrip-
sis is observed in up to 25% of samples.
Chromothripsis may lead to the genera-
tion of amplifications of one ormore onco-
genes or to the deletion of one or more
tumor suppressor genes. For example,
one small cell lung cancer cell line con-
tains a normal copy of chromosome 8
and a massively rearranged derivative
chromosome 8 with all the hallmarks of
chromothripsis. This cell line also contains
large numbers of double minute chromo-
somes comprised of 15 distinct segments
of chromosome 8, all rearranged to one
another and leading to amplification of
the MYC oncogene. Most strikingly, fluo-
rescence in situ hybridization (FISH)
experiments demonstrate that the ampli-
fied sequences on the double minute
chromosome are absent from the deriva-
tive chromosome 8. This strongly sug-
gests that a single copy of chromosome
8 shattered and that most fragments
were stitched together to generate the
derivative chromosome, but other144, January 7, 2011 ª2011 Elsevier Inc. 9
Figure 1. Stitching Together Shattered Chromosomes by Chromo-
thripsis
Chromothripsis is proposed to involve the shattering of a single chromosome,
a small group of chromosomes, or a single chromosome arm. The fragments,
or a subset of the fragments, are then stitched together by nonhomologous
end-joining. The mechanism by which these alterations are confined to a small
segment of the genome is not defined.fragments, including theMYC
gene, were stitched together
into a circular double minute
chromosome whose amplifi-
cation conferred a growth
advantage—all occurring at
the same time. In another
example, a chordoma DNA
sample exhibits a complex
rearrangement that simul-
taneously disrupts the
CDKN2A, WRN, and FBXW7
tumor suppressor genes,
each present at different
locations in the genome. In
principle, chromothripsismay
also promote cancer by gen-
eration of new fusion genes
as well. Given the complexity
of chromothriptic alterations,it will be a challenge to find a statistical
approach to determine the functional
targets of these alterations.
The authors argue that the chromo-
thriptic events are likely to occur in a single
catastrophic event rather than a series of
subsequent and random alterations.
Three pieces of evidence suggest the
possibility that chromothriptic changes
have occurred in a single event. First,
the number of copy number states found
on the altered chromosome is restricted
to two; under a model of progressive
alterations, many copy number states
would be expected. Second, in the higher
copy number states, heterozygosity is
preserved; if there were progressive
alterations, any early occurring deletion
would eliminate heterozygosity. Finally,
the alterations cluster to a greater degree
than would be expected from sequential
alterations in the chromosome. A statis-
tical analysis based onMonte Carlo simu-
lations of the progressive model is also
consistent with the view that the limited
number of copy number states is very
unlikely to have occurred by chance
through sequential alteration, again
arguing for a catastrophic or ‘‘punctuated
equilibrium’’ model.
What mechanisms could produce such
massive but highly localized changes in
the genome? The first interesting question
is how does the chromosome get shat-
tered? One well-known mechanism by
which chromosomes can be ‘‘pulverized’’
is premature chromosome compaction10 Cell 144, January 7, 2011 ª2011 Elsevier I(PCC), a phenomenon that was first ob-
served in cell fusion experiments (Rao
and Johnson, 1970; Sperling and Rao,
1974). When chromosomes from an S
phase nucleus are induced to undergo
chromosome condensation by signals
from chromosomes derived from a cell
in mitosis, the incompletely replicated
chromosomes from the S phase nucleus
shatter. It is therefore tempting to specu-
late that chromothripsis could initiate
during mitosis by a PCC-like mechanism.
The next question is how the fragments
might be stitched together. In principal,
some information about the initial shatter-
ing as well as the stitching together might
be gleaned from the sequence of the junc-
tions of the fragments on the derivative
chromosome. For example, telomere
fusions between sister chromatids are
expected to produce a large number of
head-to-head duplications (Murnane,
2006). However, chromothripsis pro-
duces highly complex derivative chromo-
somes that lack an identifiable signa-
ture—the segments on the derivative
chromosomehavebeen joinedbyaseem-
ingly random mechanism. The sequence
at the junction of each segment shows
either a lack of homology or microhomol-
ogy between the joined segments. Thus,
the main conclusion we can draw from
the sequence analysis is that the ends
are likely joined by the nonhomologous
end-joining DNA repair system.
Finally, we are left with the fascinating
puzzle of how the pulverization is confinednc.to one or two chromosomes
or to a single chromosome
arm. The underlying mecha-
nism is unclear; however, the
authors speculate that this
could possibly be linked to crit-
ical telomere shortening (Pam-
palona et al., 2010). Short telo-
meres can cause chromatid
fusion and the bridging of
dicentric chromosomes across
the cytokinetic furrow. The
resolution of bridging chromo-
somes is known to produce
nuclear protrusions and frag-
ments that, in principle, could
spatially isolateachromosome.
Altogether, the discovery of
chromothripsis by Stephens
et al. reveals a new way thatcancer genomes can evolve. In what
appears to be a single step, numerous
genes can be mutated, amplified, and re-
arranged. Because chromothripsis
occurs in such a wide variety of tumors,
the underlying mechanism is likely to
reflect as yet undefined general proper-
ties of human cancer.ACKNOWLEDGMENTS
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